Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HIND NASDAQ:OSRH NYSE:RBOT NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHINDVyome$2.16-6.1%$2.16$1.75▼$18.60$16.14M1.4838,378 shs14,266 shsOSRHOSR$0.39-6.7%$0.54$0.38▼$1.79$14.60M0.611.40 million shs954,442 shsRBOTVicarious Surgical$0.54-22.8%$0.72$0.27▼$13.75$3.82M1.7674,248 shs26,028 shsRVPRetractable Technologies$0.69+4.0%$0.68$0.60▼$1.14$20.54M1.2765,431 shs102,591 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHINDVyome+1.77%-2.13%+11.11%-17.86%+229,999,900.00%OSRHOSR-1.12%-9.55%-19.71%-18.97%-69.41%RBOTVicarious Surgical+3.78%-29.10%+61.58%+33.62%-91.70%RVPRetractable Technologies+0.41%-9.35%-8.85%-5.54%-1.95%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHINDVyome$2.16-6.1%$2.16$1.75▼$18.60$16.14M1.4838,378 shs14,266 shsOSRHOSR$0.39-6.7%$0.54$0.38▼$1.79$14.60M0.611.40 million shs954,442 shsRBOTVicarious Surgical$0.54-22.8%$0.72$0.27▼$13.75$3.82M1.7674,248 shs26,028 shsRVPRetractable Technologies$0.69+4.0%$0.68$0.60▼$1.14$20.54M1.2765,431 shs102,591 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHINDVyome+1.77%-2.13%+11.11%-17.86%+229,999,900.00%OSRHOSR-1.12%-9.55%-19.71%-18.97%-69.41%RBOTVicarious Surgical+3.78%-29.10%+61.58%+33.62%-91.70%RVPRetractable Technologies+0.41%-9.35%-8.85%-5.54%-1.95%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHINDVyome 2.40Hold$15.00594.44% UpsideOSRHOSR 1.00SellN/AN/ARBOTVicarious Surgical 1.67Reduce$7.001,205.00% UpsideRVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RBOT, RVP, HIND, and OSRH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026HINDVyome Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/4/2026HINDVyome Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/1/2026HINDVyome Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHINDVyome$320K47.39N/AN/A$0.67 per share3.22OSRHOSR$2.91M4.68N/AN/A$4.95 per share0.08RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ARVPRetractable Technologies$37.15M0.55$0.01 per share48.25$3.31 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHINDVyome-$10.26M-$12.27N/AN/AN/A-270.58%-203.92%-134.16%N/AOSRHOSR-$27.06M-$0.33N/AN/AN/A-363.26%-7.24%-5.41%N/ARBOTVicarious Surgical-$63.22M-$6.69N/AN/AN/AN/A-184.13%-112.50%7/30/2026 (Estimated)RVPRetractable Technologies-$7.01M-$0.21N/AN/AN/A-41.11%-17.15%-9.33%N/ALatest RBOT, RVP, HIND, and OSRH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.0880N/A$0.48 million5/12/2026Q1 2026HINDVyomeN/A-$0.15N/A-$0.15N/A$0.03 million3/9/2026Q4 2025RBOTVicarious Surgical-$1.37-$1.65-$0.28-$1.73N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHINDVyomeN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHINDVyomeN/A4.274.27OSRHOSRN/A0.160.14RBOTVicarious SurgicalN/A4.754.75RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHINDVyome22.06%OSRHOSR55.30%RBOTVicarious Surgical47.27%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipHINDVyome33.00%OSRHOSR36.80%RBOTVicarious Surgical9.46%RVPRetractable Technologies59.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHINDVyome507.02 million4.70 millionN/AOSRHOSRN/A35.10 million22.19 millionN/ARBOTVicarious Surgical2107.12 million5.89 millionNo DataRVPRetractable Technologies24029.94 million13.47 millionOptionableRBOT, RVP, HIND, and OSRH HeadlinesRecent News About These CompaniesRetractable Technologies (NYSE:RVP) versus Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Financial SurveyMay 27, 2026 | americanbankingnews.comRetractable Stock Slips Post Q1 Earnings, Sales Decline Y/YMay 21, 2026 | zacks.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2026May 15, 2026 | businesswire.comRetractable Technologies Shareholders Reelect Class 2 DirectorsMay 13, 2026 | tipranks.comRetractable Technologies, Inc. Announces Workforce ReductionApril 9, 2026 | businesswire.comRetractable Technologies Analyst Ratings and Price Targets | AMEX:RVP | BenzingaApril 9, 2026 | benzinga.comRVP Stock Plunges Post Q4 Earnings Despite Revenue GrowthApril 1, 2026 | zacks.comRetractable Technologies Declares Preferred Dividend Amid Tariff PressuresMarch 27, 2026 | tipranks.comRetractable Technologies: Q4 Earnings SnapshotMarch 27, 2026 | houstonchronicle.comHRetractable Technologies, Inc. Reports Results for 2025March 27, 2026 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersMarch 27, 2026 | businesswire.comRVP Stock Rises Post Q3 Earnings Despite Tariff and Cost PressuresNovember 20, 2025 | zacks.comRetractable Technologies, Inc. Results for the Periods Ended September 30, 2025November 14, 2025 | businesswire.comRetractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with NeedleNovember 14, 2025 | businesswire.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Purchases 15,000 SharesNovember 1, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 35,000 Shares of StockOctober 30, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Buys 34,506 Shares of StockOctober 29, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Acquires $13,209.72 in StockOctober 16, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Buys 30,000 SharesOctober 10, 2025 | insidertrades.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersSeptember 30, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Investors Abandoned These 3 AI Stocks Too Early, Says Jeff ClarkBy Bridget Bennett | May 21, 2026Intuit's Great SaaS Reset: Fired By AIBy Jeffrey Neal Johnson | May 22, 2026Coke's $10B India IPO Plan Pops the Top on Hidden ValueBy Jeffrey Neal Johnson | June 3, 2026Sell in May and Go Away—Starting With These 3 StocksBy Bridget Bennett | May 12, 2026RBOT, RVP, HIND, and OSRH Company DescriptionsVyome NASDAQ:HIND$2.16 -0.14 (-6.09%) Closing price 04:00 PM EasternExtended Trading$2.16 +0.00 (+0.23%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.OSR NASDAQ:OSRH$0.39 -0.03 (-6.73%) Closing price 04:00 PM EasternExtended Trading$0.39 +0.01 (+1.55%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Vicarious Surgical NYSE:RBOT$0.54 -0.16 (-22.80%) As of 03:20 PM EasternVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Retractable Technologies NYSE:RVP$0.69 +0.03 (+3.96%) Closing price 04:00 PM EasternExtended Trading$0.69 +0.00 (+0.44%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
